In Vitro and In Vivo Characterization of a Fully Felinized Therapeutic Anti‐Nerve Growth Factor Monoclonal Antibody for the Treatment of Pain in Cats-Reference-Cited by-同舟云学术

In Vitro and In Vivo Characterization of a Fully Felinized Therapeutic Anti‐Nerve Growth Factor Monoclonal Antibody for the Treatment of Pain in Cats

Author:

Gearing D.P.¹,Huebner M.²,Virtue E.R.¹,Knight K.¹,Hansen P.¹,Lascelles B.D.X.³⁴⁵,Gearing R.P.⁶,Drew A.C.¹

Affiliation:

1. Nexvet Australia Pty. Ltd. Melbourne VIC Australia

2. ClinData Services Inc. Fort Collins CO

3. Comparative Pain Research Program College of Veterinary Medicine North Carolina State University Raleigh NC

4. Comparative Medicine Institute North Carolina State University Raleigh NC

5. Center for Pain Research and Innovation UNC Chapel Hill Chapel Hill NC

6. Ridge Biotechnology Seattle WA

Publisher

Wiley

Subject

General Veterinary

Link

Reference31 articles.

3. Tanezumab, a recombinant humanized mAb against nerve growth factor for the treatment of acute and chronic pain;Cattaneo A;Curr Opin Mol Ther,2010

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献